Press Release

Clinical Trial Harnesses Power of Natural Killer Cells to Treat Neuroblastoma

FOR IMMEDIATE RELEASE   Clinical Trial Harnesses Power of Natural Killer Cells to Treat Neuroblastoma   Nov 13, 2018 New York City— Researchers have made rapid advances in understanding how to manipulate the immune system safely to destroy cancer cells. Adoptive transfer of haploidentical natural killer (NK) cells has shown promise as a treatment option…

Read More

Transatlantic Clinical Trial For Children With Neuroblastoma is Open For Enrollment in the U.K. – Soon to Open in The U.S. and Germany

June 11, 2018 FOR IMMEDIATE RELEASE TRANSATLANTIC CLINICAL TRIAL FOR CHILDREN WITH NEUROBLASTOMA IS OPEN FOR ENROLLMENT IN THE U.K. – SOON TO OPEN IN THE U.S. AND GERMANY Charities Collaborate to Initiate International Phase 1 Clinical Trial  for Children with Neuroblastoma   June 1, 2018 – NEW YORK – Solving Kids’ Cancer has partnered with Band…

Read More

The Childhood Cancer STAR Act has been signed!

The Childhood Cancer Star Act of 2017 is now law, a landmark moment for the childhood cancer community.  You can find a summary of the new law, signed on June 5, 2018 by President Trump, below. The passage of the STAR Act was a true community effort that involved years of patience, hard work, and…

Read More

Solving Kids’ Cancer 2018 Spring Celebration

Solving Kids’ Cancer Closer to Cures Honoring Usman “Oz” Azam, MD President & CEO Tmunity  Therapeutics Thomas Gad Founder & President Y-mAbs Therapeutics with  Master of Ceremonies, Mikhail “Doctor Mike” Varshavski, World’s Most Followed Doctor Hosted by Gabby & Gianpaolo, De Felice, Lindy Gad, Angelina Jolin, Jan Planit, Frederique van der Wal, and Bonnie Young…

Read More

Brain Tumor Clinical Trial Now Enrolling Children

November 16, 2017 – DURHAM, NC: A Phase 1 clinical trial leveraging the re-engineered polio virus is now open for enrollment to children 12 years and older at the Preston Robert Tisch Brain Tumor Center, Duke University Medical Center. After years of following the progress of this promising therapy against adult glioblastoma and working with…

Read More

Targeted Therapy for Children with ALK-Driven Neuroblastoma

Lorlatinib may prove effective for the treatment of neuroblastoma. Solving Kids’ Cancer is leading an international effort of like-minded nonprofits to provide nearly $400,000 of collaborative funding for an innovative clinical trial to bring a potentially life-saving therapy to kids.

Read More

Advocacy in Action

Solving Kids` Cancer was the first charity to ever go against the UK healthcare system without a pharmaceutical company involved. As a result, the National Institute for Health and Care Excellence (NICE) recently announced that it has upheld SKC`s appeal against the Institute’s decision not to recommend dinutuximab for treating high-risk neuroblastoma. 

Read More